Gene Expression Signatures to Predict the Development of Metastasis in Breast Cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Breast Disease

• Publication date

  2007-04-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/BD-2007-26113PMID 17473373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.

  2006cited by this paper
• Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers

  2006cited by this paper
• Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

  2006cited by this paper
• Proliferation: the Most Prominent Predictor of Clinical Outcome in Breast Cancer

  2006cited by this paper
• Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.

  2006cited by this paper
• Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

  2006cited by this paper
• Genetic regulators of large-scale transcriptional signatures in cancer

  2006cited by this paper
• Concordance among gene-expression-based predictors for breast cancer.

  2006cited by this paper
• Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

  2006cited by this paper
• Lysyl oxidase is essential for hypoxia-induced metastasis

  2006cited by this paper
• Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.

  2005cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Determination of Stromal Signatures in Breast Carcinoma

  2005cited by this paper
• Mechanism-derived gene expression signatures and predictive biomarkers in clinical oncology.

  2005cited by this paper
• Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

  2005cited by this paper
• Supplemental Data Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

  2005cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Prediction of cancer outcome with microarrays: a multiple random validation strategy.

  2005cited by this paper
• Multi-center validation of the 76-gene prognostic signature in lymph node negative (LNN) primary breast cancer

  2005cited by this paper
• Stromal fibroblasts in cancer initiation and progression

  2004cited by this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cited by this paper
• A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

  2004cited by this paper
• Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds

  2004influential reference
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004influential reference
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• The transcriptional program in the response of human fibroblasts to serum.

  1999cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

  1986cited by this paper

• A specific gene expression signature for visceral organ metastasis in breast cancer

  2019cites this paper
• Surgical and Locoregional Treatment of DCIS and Early-Invasive Breast Cancer

  2016influential citation
• ESSENTIAL ROLE OF B-CELL LYMPHOMA-9 IN HUMAN BREAST DUCTAL CARCINOMA IN SITU PROGRESSION TO INVASIVE BREAST CANCER

  2015cites this paper
• Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells

  2015cites this paper
• Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes

  2014cites this paper
• Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer

  2013cites this paper
• Università degli Studi di Milano Scuola di Dottorato in Medicina Molecolare

  2012cites this paper
• The regulation of type I collagen gene expression in stromal fibroblast by breast tumour cells

  2011cites this paper
• Surgical and local-regional treatment of "early" invasive breast cancer.

  2011influential citation
• 14-3-3σ Expression Identifies Basal-Like Breast Cancer and Regulates Tumor Invasion by Defining Subcellular Regions of Actin Polymerization

  2010cites this paper
• The microRNA network and tumor metastasis

  2010cites this paper
• Prognostic outcomes and decision-making for local-regional therapy after neoadjuvant chemotherapy: Pretreatment clinical staging or posttreatment pathologic staging?

  2009cites this paper
• Multigene Classifiers, Prognostic Factors, and Predictors of Breast Cancer Clinical Outcome

  2009cites this paper
• Molecular markers of breast axillary lymph node metastasis

  2009cites this paper
• Stromal gene expression predicts clinical outcome in breast cancer

  2008cites this paper
• Staging of breast cancer in the neoadjuvant setting.

  2008cites this paper
• Natural history and prognostic factors in localized prostate cancer

  2008cites this paper
• Commercialized multigene predictors of clinical outcome for breast cancer.

  2008cites this paper
• Natural history and prognostic factors in localized prostate cancer

  2008cites this paper
• Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.

  2008cites this paper
• Supplementary Issue: Network and Pathway Analysis of Cancer Susceptibility (a)

  year unknowncites this paper